Infectious Diseases

Hypertetraploid Partial Molar Pregnancy Identified by Microarray and STR Analysis, with Subsequent Choriocarcinoma Diagnosis
Elizabeth Barrie, PhD, Nationwide Children's Hospital, Columbus, OH, USA

Research Whole Exome Sequencing Identifies a Novel SH2D1A Variant in a 51-Year-Old Patient with CNS Lymphocytic Vasculitis
Patrick Blackburn, PhD, Mayo Clinic, Rochester, MN, USA

Acute Liver Failure Due to Echovirus 9 Associated with Persistent B Cell Depletion from Rituximab
Alex Greninger, MD, PhD, University of Washington, Seattle, WA, USA

Pyrosequencing Solves the Case of the Conflicting Bacterial Isolates
Damon Olson, MD, Baylor College of Medicine, Houston, TX, USA

HPV and Head and Neck Cancer
Joseph A. Califano, MD, University of California, San Diego, CA, USA

Blood-based Assessment of EBV DNA as a Tumor Marker
Jennifer A. Kanakry, MD, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Microbial Anthropology
Maria G. Dominguez-Bello, PhD, BSc, MSc, New York University School of Medicine, New York, NY, USA

A Collaborative Effort to End the Pandemic Era: The Global Virome Project
Jonna Mazet, DVM, MPVM, PhD, One Health Institute, University of California, Davis, CA,USA

Gene Expression Profiling During Infection Using Digital Barcoded Probe Technology
Aaron P. Mitchell, PhD, Carnegie Mellon University, Pittsburgh, PA, USA

Implementation of a Diagnostic Device Syndromic Disease Network
Lindsay Meyers, BSc, BioFire Diagnostics, LLC, Salt Lake City, Utah, USA

Introduction to Smarticles™ Technology: Potential Applications in Antimicrobial Stewardship
Michael Lewinski, PhD, Roche Molecular Systems, Inc., Pleasanton, CA, USA

Molecular Point-of-Care Tests for Infectious Diseases: Opportunities and Challenges
Frederick S. Nolte, PhD, Medical University of South Carolina, Charleston, SC, USA

ID74 - Detection of Resistance-Associated Substitutions in the Hepatitis C Viral Genome using the Sentosa SQ Hepatitis C Virus Genotyping Next-Generation Sequencing Assay
Jonas Pettersson, PhD, University of Southern California, Los Angeles, CA, USA

ID02 - Pathogen Detection by Metagenomic Next Generation Sequencing of Purulent Body Fluids
Wei Gu, MD, PhD, University of California, San Francisco, CA, USA

ID34 - Challenges Associated with Developing Rapid Molecular Diagnostics for Detection of Antibiotic Resistance
Megan Stonebraker, Diatherix Laboratories, Huntsville, AL, USA

ID60 - Extreme One-Step RT-PCR: Potential for Point-of-Care Viral Detection
Jessica A. Houskeeper, MRes, University of Utah, Salt Lake City, UT, USA

Panel Discussion
Gregory A. Storch, MD, Washington University School of Medicine, St. Louis, MO, USA

Kimberly Hanson, MD, MHS, University of Utah, Salt Lake City, UT, USA

Passing the Baton: Keys to Successful Implementation of Laboratory Developed Tests (LDTs) and FDA-cleared Tests
Melissa R. Johnson, BSc, ARUP Laboratories, Salt Lake City, UT, USA

Jeff Stevenson, PhD, ARUP Laboratories, Salt Lake City, UT, USA

Jeffrey Chumley, BSc, ARUP Laboratories, Salt Lake City, UT, USA

Bacterial Resistance: Detection with Molecular Methods
Robert A. Bonomo, MD, Louis Stokes VA Medical Center, Cleveland, OH, USA

 

Deep Sequencing for HIV-1 Clinical Management
Maria Casadellà, PhD, IrsiCaixa AIDS Research Institute, Barcelona, Spain

 

Diagnosis of Clostridium difficile Infections: The Benefits of Molecular Testing
Ferric C. Fang, MD, University of Washington, School of Medicine, Seattle, WA, USA

Diagnosis of Clostridium difficile Infections: Why Toxin Tests Still Matter
Christopher R. Polage, MD, University of California, Davis School of Medicine, Sacramento, CA, USA